This report provides updates to opioid training programs to certain individuals in administering opioid antagonists at the HRA’s HIV AIDS Services Administration (HASA) and the Department of Homeless Services.
The Tobacco Product Regulation Act Report, pursuant to Local Law 69 of 2009, contains information regarding tobacco inspection activity during Grant Year XXVI, April 1, 2023, to March 31, 2024.
Pursuant to Local Law 92 of 2022, this report features reporting on the Department of Health and Mental Hygiene’s opioid antagonist training and kit distribution to nightlife employees for CY2023.
Pursuant to Local Law 92 of 2022, this report features reporting on the Department of Health and Mental Hygiene’s opioid antagonist training and kit distribution to nightlight employees for CY2023.
In accordance with the New York City Administrative Code §17-1001 (as amended by Local Law No. 19 of 2005), this report summarizes the Prescription Drug Discount Card Program, known as BigAppleRx, updated to include the period January 1, 2022, to December 31, 2022.
This report provides updates to opioid training programs to certain individuals in administering opioid antagonists at the HRA’s HIV AIDS Services Administration (HASA) and the Department of Homeless Services.
Pursuant to section 17-711 of the New York City Administrative Code, this report describes the administration and enforcement of the Tobacco Product and Regulation Act.
The New York City Municipal Drug Strategy Council (MDSC) is a body of government and community experts in substance use and substance use care and treatment. This report includes an overview of current drug strategy and progress made during the past two years and offers recommendations.
In accordance with the New York City Administrative Code §17-1001 (as amended by Local Law No. 19 of 2005), this report summarizes the Prescription Drug Discount Card Program, known as BigAppleRx. This report includes the period January 1, 2021, to December 31, 2021.
This report provides updates to opioid training programs to certain individuals in administering opioid antagonists at the HRA’s HIV AIDS Services Administration (HASA) and the Department of Homeless Services.